PharmDr. Peter KOLLÁR, Ph.D. (deputy head)

 

Education and academic qualifications

  • 2005: Attestation – Clinical Pharmacy Grade I., IPVZ Prague, Czech Republic
  • 2003: Ph.D. in Pharmacology and Toxicology, Pharmaceutical Faculty, VFU Brno
  • 2002: PharmDr. in Pharmacology, Pharmaceutical Faculty, VFU Brno
  • 1998: Mgr., Pharmaceutical Faculty, VFU Brno, Czech Republic

Professional experience

  • 2003-: Senior Lecturer, Department of Human Pharmacology and Toxicology, VFU Brno
  • 1998-2003: Assistant, Department of Human Pharmacology and Toxicology, VFU Brno

Teaching activities

  • Course Guarantor of: Pharmacokinetics, Pharmacology; Courses and seminars in: Pharmacology, Toxicology, Pharmacotherapy and Clinical Pharmacology, Pathological physiology, Pharmacological and Social Aspects of OTC Drugs
  • 1998 – 2013: supervision of 30 diploma theses, 19 advanced diploma thesis, 2 Ph.D. students, and 3 Erasmus program students

Research activities

            Tissue culture methods used in:

  • Characterization and evaluation of cytotoxicity and effect of newly synthesized and new natural compounds (focus on cell cycle, cytodifferentiation, inflammation, and apoptosis)
  • Evaluation of new pharmaceutical products based on polysaccharides

Professional stays abroad

  • 2007: ERASMUS program for teachers – Ankara University, Faculty of Pharmacy, Ankara, Turkey
  • 2004: EUROTOX Basic Toxicology Course, Lublaň, Slovinsko
  • 2001-2002: Visiting Scientist in the Laboratory of Molecular Biology, Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milan, Italy

Other academic activities, research projects, grants

  • Member of State Exams Committee of  Faculty of Science of Masaryk University Brno (2012-)
  • Member of State Exams Committee of  Pharmaceutical Faculty VFU Brno (2009-)
  • Chairman of Rigorous Study Committee (2006-)
  • Board of Academic Senate of Pharmaceutical Faculty VFU Brno (2005-)

Grants:

2001    – FRVŠ, (1300/2001)

2006    – FRVŠ, (255/2006)

2006    – IGA VFU Brno, (29/2006/FaF)

2006    – IGA VFU Brno, (27/2006/FaF)

2006    – MŠMT, (No. 654)

2006    – MPO, (2A-1TP1/073)

2008    – IGA VFU Brno, (161/2008/FaF)

2009    – FRVŠ, (1552/2009)

2009    – IGA VFU Brno, (232/2009/FAF)

2010    – IGA VFU Brno, (3/2010/FaF)

2010    – MŠMT, (No. 18/5)

2011    – TAČR, 3 years (TA01010244)

2011    – IGA VFU Brno, (62/2011/FaF)

2012    – GAČR, 5 years, (P503/12/0337)

2012    – ESF, MŠMT OPVK, mentor, 3 years, (CZ.1.07/2.3.00/30.0053)

Non-university activities

  • Member of British Pharmacological Society (2011- )
  • Czech Medical Association of J. Ev. Purkyně (2010-)
  • Czech Pharmacists´ Chamber (1998-)

Most significant professional accomplishments

  • Detection of mechanisms of anti-inflammatory and anticancer effects of newly isolated natural products of geranylated and prenylated flavonoid character
  • Participation in the characterization of toxicity and biological effects of new carboxymethyl cellulose types
  • Participation in the characterization of biological effects of new compounds (bis-indols) enhancing efficacy of ATRA (all-trans retinoc acid) in acutne promyelocytic leukemia therapy

Major publications

 

  • Pisano C, KOLLAR P, Gianni M, Kalac Y, Giordano V, Ferrara FF, Tancredi R, Devoto A, Rinaldi A, Rambaldi A, Penco S, Marzi M, Moretti G, Vesci L, Tinti O, Carminati P, Terao M, Garattini E. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells. Blood. 2002, vol. 100, no. 10, p. 3719-3730. ISSN: 0006-4971, IF2002: 10,12
  • KOLLaR P, Barta T, Zavalova V, Smejkal K, Hampl A. Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP-1) cells. British Journal of Pharmacology. 2011, vol. 162, no. 7, p. 1534-1541. ISSN: 0007-1188, IF2011: 4,409
  • KOLLAR P, Zavalova V, Hosek J, Havelka P, Sopuch T, Karpisek M, Tretinova D, Suchy P Jr. Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells. International Immunopharmacology. 2011, vol. 11, no. 8, p. 997-1001. ISSN: 1567-5769, IF: 2,376
  • Pencikova K, KOLLaR P, Müller Zavalova V, Taborska E, Urbanova J, Hosek J. Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line. Phytomedicine. 2012, vol. 19, no. 10, p. 890–895. ISSN: 0944-7113, IF2011: 3,268
  • Fajkusova D, Pesko M, KELTOSOVA s, Guo J, Oktabec Z, Vejsova M, Kollar P, Coffey A, Csollei J, Kralova K, Jampilek J. Anti-infective and herbicidal activity of N-substituted 2-aminobenzothiazoles. Bioorganic & Medicinal Chemistry. 2012, vol. 20, no. 24, p. 7059-7068. ISSN: 0968-0896, IF2011: 2,921
  • Gonec T, Bobal P, Sujan J, Pesko M, Guo J, Kralova K, Pavlacka L, Vesely L, Kreckova E, Kos J, Coffey A, Kollar P, Imramovsky A, Placek L, Jampilek J. Investigating the Spectrum of Biological Activity of Substituted Quinoline-2-Carboxamides and Their Isosteres. Molecules. 2012, vol. 17, no. 1, p. 613-644. ISSN: 1420-3049, IF2011: 2,386
  • Hosek J, Bartos M, Chudik S, Dall´Acqua S, Innocenti G, Kartal M, Kokoska L, Kollar P, Kutil Z, Landa P, Marek R, Zavalova V, Zemlicka M, Smejkal K. Natural Compound Cudraflavone B Shows Promising Anti-inflammatory Properties in vitro. Journal of Natural Products. 2011, vol. 74, no. 4, p. 614-619. ISSN: 0163-3864, IF2011: 3,128
  • smejkal K, Svacinova J, Slapetova T, Schneiderova K, Dall'acqua S, Innocenti G, Zavalova V, Kollar P, Chudik S, Marek R, Julinek O, Urbanova M, Kartal M, Csöllei M, Dolezal K. Cytotoxic Activities of Several Geranyl-Substituted Flavanones. Journal of Natural Products. 2010, vol. 73, no. 4, p. 568-572. ISSN: 0163-3864, IF2010: 2,872